Characterizing a drug's primary binding site on albumin

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 333-343

  Day, Yasmina S N ^a   Myszka, David G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin; Biacore; Binding sites; Biosensor; Surface plasmon resonance

Indexed keywords

ALBUMIN; CORTICOSTERONE; COUMARIN DERIVATIVE; DANSYL CHLORIDE; DICOUMAROL; DIGITOXIN; FLUORIDE; IBUPROFEN; NAPROXEN; PHENYLBUTAZONE; QUININE; SALICYLIC ACID; WARFARIN;

ARTICLE; BINDING AFFINITY; BIOSENSOR; DRUG BINDING SITE; DRUG PROTEIN BINDING; MOLECULAR WEIGHT; PROTEIN STABILITY; SURFACE PLASMON RESONANCE;

EID: 0037308418     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10293     Document Type: Article

References (17)

1. Peters T Jr. 1996. All about albumin. San Diego, CA: Academic Press.
2. Frostell-Karlsson Å, Remaeus A, Roos H, Andersson K, Borg P, Hämäläinen M, Karlsson R. 2000. Biosensor analysis of the interactions between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J Med Chem 43:1986-1992.
3. Rich RL, Day YSN, Morton TA, Myszka DG. 2001. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Anal Biochem 296:197-207.
4. Myszka DG, Rich RL. 2000. Implementing surface plasmon resonance biosensors in drug discovery. Pharm Sci Technol Today 3:310-317.
5. Johnsson B, Löfås S, Lindquist G. 1991. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198:268-277.
6. Myszka DG. 1999. Improving biosensor analysis. J Mol Recognit 12:279-284.
7. Sudlow G, Birkett DJ, Wade DN. 1976. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12:1052-1061.
8. Perrin JH, Vallner JJ, Nelson DA. 1975. Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin. Biochem Pharmacol 24:769-774.
9. 1-acid glycoprotein. J Pharmacobio-Dyn 15:7-16.
10. Dockal M, Chang M, Carter DC, Rüker F. 2000. Five recombinant fragments of human serum albumin - Tools for the characterization of the warfarin binding site. Protein Sci 9:1455-1465.
11. Epps DE, Raub TJ, Kézdy FJ. 1995. A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Anal Biochem 227:342-350.
12. Maes V, Engelborghs Y, Hoebeke J, Maras Y, Vercruysse A. 1982. Fluorometric analysis of the binding of warfarin to human serum albumin. Mol Pharmacol 21:100-107.
13. Vestberg K, Galliano M, Minchiotti L, KraghHansen U. 1992. High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. Biochem Pharmacol 44:1515-1521.
14. Whitlam JB, Crook MJ, Brown KF, Pedersen PV. 1979. Binding of nonsteroidal anti-inflammatory agents to proteins. I. Ibuprofen-serum albumin interaction. Biochem Pharmacol 28:675-678.
15. Sudlow G, Birkett DJ, Wade DN. 1975. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11:824-832.
16. Garten S, Wosilait W. 1971. Comparative study of the binding of coumarin anticoagulants and serum albumins. Biochem Pharmacol 20:1661-1668.
17. Sellers EM, Koch-Weser J. 1971. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann NY Acad Sci 179:213-225.